Brief: Kintor Pharmaceutical Posts HY Adjusted Loss RMB468.6 Million
29/08/2022 16:05
Aug 29 (Reuters) - Kintor Pharmaceutical Ltd 9939.HK :
* HY ADJUSTED LOSS RMB468.6 MILLION VERSUS LOSS RMB299.9
MILLION
Source text for Eikon: ID:nHKS1pkmBg
Further company coverage: 9939.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Kintor Pharmaceutical
See all newsBrief: Kintor Pharmaceutical Receives Invention Patent Grant For KT-939 In China
Brief: Kintor Pharmaceutical Says Ming Ming Cheung Resigns As CFO
Brief: Kintor Pharmaceutical Says CEO Via Wholly Owned Co Increases Shareholding By 2.51 Million Shares
Brief: Kintor Pharmaceutical Says YTD 2026 Sales Revenue At RMB34 Million
Brief: Kintor Pharmaceutical Says Pharma's Kx-826 Phase Iii Trial In China Reaches Primary Endpoint